Literature DB >> 11847490

Concordance of acute and transient psychoses and cycloid psychoses.

F Pillmann1, A Haring, S Balzuweit, R Blöink, A Marneros.   

Abstract

OBJECTIVE: We prospectively investigated a sample of 42 patients with acute and transient psychotic disorder (ATPD) as defined by the 10th revision of the International Classification of Diseases (ICD-10; F23) to determine the clinical and demographic features of this entity and its relationship to cycloid psychoses.
METHODS: During a 5-year period, all in-patients with ATPD were identified. We systematically evaluated demographic and clinical features and carried out follow-up investigations on average 2 years after the index episode, using standardised instruments.
RESULTS: We found 42 cases of ATPD (4.1%) among 1,036 patients treated for psychotic disorders or a major affective episode. There was a marked female preponderance in ATPD (79%). Fifty-five percent of cases concurrently met the criteria of cycloid psychosis according to Perris and Brockington [in Perris C, Struwe G, Jansson B (eds): Biological Psychiatry. Amsterdam, Elsevier, 1981, pp 447-450]. There was no difference in gender distribution between cycloid and non-cycloid ATPD. As expected, abrupt onset and polymorphic features were significantly more common in cycloid than in non- cycloid ATPD. At follow-up, patients with cycloid ATPD showed less persistent alterations and better social functioning.
CONCLUSION: ATPD as defined by ICD-10 is a heterogeneous category. A diagnosis of cycloid psychosis is made in half of the cases of ATPD, and in these cases, the prognosis is more favourable. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11847490     DOI: 10.1159/000049329

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  9 in total

1.  McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients.

Authors:  Paola Salvatore; Ross J Baldessarini; Mauricio Tohen; Hari-Mandir K Khalsa; Jesus Perez Sanchez-Toledo; Carlos A Zarate; Eduard Vieta; Carlo Maggini
Journal:  J Clin Psychiatry       Date:  2010-07-13       Impact factor: 4.384

Review 2.  [Acute and transient psychotic disorders (ICD-10: F23). Empirical data and implications for therapy].

Authors:  M Jäger; M Riedel; H-J Möller
Journal:  Nervenarzt       Date:  2007-07       Impact factor: 1.214

Review 3.  Nonaffective acute psychoses: uncertainties on the way to DSM-V and ICD-11.

Authors:  Katie L Nugent; Diana Paksarian; Ramin Mojtabai
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

Review 4.  Acute and Transient Psychotic Disorders: Newer Understanding.

Authors:  Savita Malhotra; Swapnajeet Sahoo; Srinivas Balachander
Journal:  Curr Psychiatry Rep       Date:  2019-11-04       Impact factor: 5.285

5.  [Comparative study of life quality in patients with cycloid and schizophrenic psychoses].

Authors:  B Jabs; U Krause; G Althaus; G Stöber; B Pfuhlmann
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

Review 6.  Acute and transient psychotic disorders (ICD-10 F23): a review from a European perspective.

Authors:  Augusto Castagnini; German E Berrios
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-04-21       Impact factor: 5.270

Review 7.  Cycloid psychosis: an examination of the validity of the concept.

Authors:  Victor Peralta; Manuel J Cuesta; Maria Zandio
Journal:  Curr Psychiatry Rep       Date:  2007-06       Impact factor: 5.285

8.  Proteomic profile of serum from patients with schizophrenia spectrum disorders.

Authors:  Elena Dmitrieva; Liudmila Smirnova; Alexander Seregin; Victor Zgoda; Arkadij Semke; Svetlana Ivanova
Journal:  PeerJ       Date:  2022-08-30       Impact factor: 3.061

Review 9.  Wernicke-Kleist-Leonhard phenotypes 
of endogenous psychoses: a review of their validity
.

Authors:  Jack R Foucher; Micha Gawlik; Julian N Roth; Clément de Crespin de Billy; Ludovic C Jeanjean; Alexandre Obrecht; Olivier Mainberger; Julie M E Clauss; Julien Elowe; Sébastien Weibel; Benoit Schorr; Marcelo Cetkovich; Carlos Morra; Federico Rebok; Thomas A Ban; Barbara Bollmann; Mathilde M Roser; Markus S Hanke; Burkhard E Jabs; Ernst J Franzek; Fabrice Berna; Bruno Pfuhlmann
Journal:  Dialogues Clin Neurosci       Date:  2020-03       Impact factor: 5.986

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.